NEWS


News & events

Our seminars

This calendar invitation is to announce our speaker in the context of Samantha Rustichelli’s SEMM thesis defense and share the “save-the-date”

** 22/10/2026 - h. 14:00
speaker: Aliaksandra Radzisheuskaya, ICR-Institute of Cancer Research, London (UK)
title: Epigenetic control through histone modifications: dissecting functions across normal and cancer biology
host: IEO-Pasini
location: Ivory + Silver Rooms **

https://www.radzisheuskayalab.com/

https://www.icr.ac.uk/research-and-discoveries/find-a-researcher/test-researcher-profile-detail/dr-alex-radzisheuskaya

Short Bio:
Aliaksandra (Alex) Radzisheuskaya is a Tenure-Track Group Leader at the Institute of Cancer Research (ICR) in London, where she leads the Chromatin Biology Group. She obtained her PhD in Biochemistry from the University of Cambridge, studying gene regulation in pluripotent stem cells, following a BSc in Molecular Biology from the University of Edinburgh. Before establishing her independent group, Alex was an independent ICR Fellow and, before that, a postdoctoral researcher in Prof Kristian Helin’s laboratory at the University of Copenhagen and Memorial Sloan Kettering Cancer Center. Her research focuses on chromatin and epigenetic regulation, with particular interest in acute myeloid leukaemia.

Epigenetic control through histone modifications: dissecting functions across normal and cancer biology

October 22, 2026 14:00

our last paper

SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.

SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.

Serrano D, Rizzo R, Johansson H, Macis D, Aristarco V, Guerrieri-Gonzaga A, Lazzeroni M, Aurilio G, Carbone A, Ramalho S, Bonanni B, DeCensi A, Gandini S
Sep , 2026

Upcoming event

SAVE THE DATE!

SAVE THE DATE!

highlight

New EU-LIFE booklet celebrating 30 years of MSCA

New EU-LIFE booklet celebrating 30 years of MSCA

highlight

The EU-LIFE Postdoctoral Exchange Programme

The EU-LIFE Postdoctoral Exchange Programme

Our SCIENCE


Research & technology

Our science
Principal Investigators
Technological Units
Translational Research Programs
Technology Transfer Office (IEO-TT)
Visiting scholars

Our MENTORING


Education & training

Our mentoring
Undergraduate Students
PhD Students
Postdoctoral Fellows
Technicians

Our ALLIANCES


Partners & Networks

JOIN us


Explore our open positions

Postdoctoral position for Computational Biologist (Ref. 2026-05-LN/22)

Postdoctoral position for Computational Biologist - Luigi Nezi's lab

Reference 2026-05-LN/22

READ MORE
Postdoctoral Position in Cancer Epigenetics and Proteomics (Ref. 2026-06-TB/28)

Postdoctoral Position in Cancer Epigenetics and Proteomics - Bonaldi's lab

Reference 2026-06-TB/28

READ MORE
Computational postdoc position in Martin Schaefer's lab (Ref. 2026-06-MS/32)

Computational postdoc position - Martin Schaefer's lab

Reference 2026-06-MS/32

READ MORE
Postdoctoral Research Fellow in Cancer Biology and Translational Oncology (Ref. 2026-07-DT/35)

Postdoctoral Research Fellow in Cancer Biology and Translational Oncology - Hormone-Related Cancers and Stem Cell Pathobiology Unit

Reference 2026-07-DT/35

READ MORE

Over the past 30 years since DEO’s founding, numerous scientists have launched and advanced their careers here. This has created a broad community of researchers who, despite being spread across institutes worldwide, still cherish their experiences at IEO and maintain strong ties to the department. In 2018, DEO held its inaugural Alumni meeting, bringing together 50 former PhD students, postdocs, and Group Leaders, now Principal Investigators or Institute Directors internationally, to reconnect and engage in scientific discussions.

READ
Kristian Helin

Kristian Helin

IEO Group Leader 1997‑2012

VIEW DETAILS

SUPPORT us


In Italy, taxpayers have the option to donate 0.5% of their taxes to non-profit organizations through the “Cinque per mille” (5x1000) scheme.

When submitting your income tax return via the 730 or CUD forms, you can designate 5x1000 of your tax to the European Institute of Oncology (IEO), helping to advance research, innovation, and treatment.

Clinical activities at IEO are conducted at the IEO Hospital on Via Ripamonti.
IEO’s core values focus on prioritizing patients’ needs and pursuing ongoing self-improvement to achieve excellence in clinical care and research, all within a multidisciplinary framework